Search

everythinglearnresearchcommunity

for

Search:↓

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone is crucial for development, growth, and various body functions in mammals.

The article concludes that a balance is needed between individual healthcare needs and societal resources when it comes to lifestyle drugs, with a call for compassionate policy application.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Hair loss can be reversed or even cured using advanced hair restoration techniques, with rare complications like swelling and bleeding.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.